Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 81809

AbstractMaterial and MethodsResultsAcknowledgementReferences
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2009 | Month : June | Volume : 3 | Issue : 3 | Page : 1493 - 1499 Full Version

Improved Method For Detection Of Methylation Status Of Genes From Limited, Archived, FFPE And FNAC Samples.


Published: June 1, 2009 | DOI: https://doi.org/10.7860/JCDR/2009/.519
SAHOO R*, BANERJEE A**,PAYAL K***, WANI S****, KORLIMARLA A*****, BABU V C ******,PRABHU J S *******,

TRIESTA SCIENCES INDIA PVT. LTD. Bangalore - 27 (India)

Correspondence Address :
Dr. Rashmita Sahoo, Ph.D Senior Scientist, Triesta Sciences (I) Private Limited, Ist Floor, HCG Tower, #8, P. Kalinga Rao Road, Sampangiram Nagar, Bangalore-27,(India)Email: rashmita@triesta.com Ph-08040206104/05

Abstract

Purpose: Bisulphite modified genomic DNA and downstream analysis methods are the most powerful techniques which are used to determine the methylation of chromosomal DNA and the promoter region. However, the amount of material available is the most limiting factor, which continuously leads to the development of the most sensitive and specific method of methylation determination. In the present communication, we present an improved modification of bisulphite conversion and MSP.
Method: Our strategy is the bisulphite conversion of direct tissue sections in the tube, followed by DNA purification and methylation specific PCR.
Results: Our results successfully yielded a high amount of methylated DNA and showed promoter methylation amplification using very scanty biopsy sample, other clinical FFPE tissues and FNAC cells. A large no of genes could be studied, which otherwise would not be feasible using the conventional method of DNA isolation and bisulphite modification.
Conclusion: Our method improves substantially, the previously published protocol in terms of yield, quality using a limited amount of tissue from formalin fixed material and cytology smears from fine needle aspirates.
Abbreviations: sFRP1: secreted frizzled-related proteins 1, MGMT (O6-methylguanine-DNA methyltransferase), FFPE: Formalin fixed paraffin embedded, FNA: Fine needle aspirate, MSP: methylation specific PCR

Keywords

Methylation, FFPE, FNA

Introduction
Epigenetic gene silencing by promoter hypermethylation of tumour suppressor genes is known to play a significant role in the malignant transformation of tumour cells (1),(2). More recently, the attention of investigators has shifted to the study of cancer associated regional hypermethylation at specific CpG islands of selected genes and its association to transcriptional silencing. The assessment of promoter hypermethylation of tumour suppressor genes has become important for understanding the mechanisms of malignant transformation.

Several methods have been standardized in the recent past for the assessment of the methylation status of the specific sites which range from primitive cumbersome manual techniques to high throughput automated assays(3),(4),(5),(6). Bisulphite modification of the genomic DNA, followed by alkaline treatment which converts only unmethylated cytosine to uracil, sparing the 5 methyl cytosines, is one such commonly used method. Sequence variants at particular loci can subsequently be analyzed by PCR amplification with primers designed to anneal with bisulphite converted DNA. Though the conventional method of bisulphite modification is a well-standardized technique for methylation specific PCR (MSP) (4), the application of the same to formalin fixed paraffin embedded (FFPE) tissues has certain disadvantages. In the recent past, the value of the FFPE samples has been recognized and consequently, nucleic acids derived from these FFPE blocks are being used in various gene expressions, gene amplification studies and for the validation of biomarkers in many retrospective studies (7),(8),(9). However, the FFPE tissue is still considered as a difficult substrate due to the extensive cross linking of proteins and the degradation and fragmentation of the macromolecules caused by formalin fixation (10),(11). Though great advances have been made in the development of sensitive techniques for the utilization of formalin fixed material for molecular analysis (7),(8),(9), the assessment of gene methylation in FFPE tissues is still challenging due to a small volume of tissue and excessive DNA fragmentation.

Studies have reported a significant loss of template DNA during the conventional bisulphite modification and this seriously hampers the assessment of the methylation status of multiple genes by MSP (12). Loss of template DNA also becomes critical when a limited amount of tissue material is available from archived human samples. Few methods have tried to overcome this disadvantage by the in situ bisulphite modification of the genomic DNA before extraction, thereby reducing the significant loss of template DNA (13). Here, we describe a method for the bisulphite modification of a limited amount of material obtained from FFPE and fine needle aspirate samples. Using this method, we have tested the promoter methylation status of commonly methylated genes like O6-methylguanine-DNA methyltransferase (MGMT) in brain tumours and secreted frizzled-related proteins (sFRP1), in tissue samples from colon and breast cancers and in samples of liver biopsy and have compared it to the conventional method of bisulphite modification.

Material and Methods

Tissue Specimens
We studied the methylation status of multiple genes in formalin fixed paraffin embedded tissues from 27 samples. Of these, 23 were formalin fixed paraffin embedded materials comprising of 11 cases of adenocarcinoma of colon, 5 cases of infiltrating ductal carcinoma of the breast, 5 liver biopsies from cirrhosis of liver and 2 gliomas arising of the brain tissue. The remaining four were Haematoxylin and Eosin stained smears from fine needle aspirated material which was diagnosed as breast cancer.

These samples were obtained from the hospital repository with clearance from the hospital ethical committee. Hematoxylin and Eosin staining was done for all the FFPE samples which were selected to identify tissue blocks containing representative tissue material occupying more than 80% of the area. The tissue sections measured approximately 0.5 X 0.5 cms in area, except for the liver biopsies which measured 0.2 X 0.5 cm in size. One 10 µm thick section was cut from the selected blocks for bisulphite modification.

For smears from fine needle aspirates, the cover glass was removed after 24-36 hrs of treatment with Xylene, depending on the age of the slide and cellular material was scraped into the tube for bisulphite modification.

Bisulphite Modification By In- Tube Method (Patent Filed 366/CHE/2008)
A 10µm thick section was taken in a 1.7 ml eppendorf tube and was deparaffinized using two changes of Xylene for 15 minutes each and was dehydrated in graded alcohol. Sections were rehydrated in distilled water for 5 minutes and were denatured by 0.2M NaOH for 10 minutes. They were washed in distilled water again for 5 minutes and were incubated in 3M sodium bisulphite with 0.5mM hydroquinone for 8 hours at 60 degC. The sections were rinsed in distilled water for 10 minutes and were treated with sodium hydroxide to remove adducts. The sections were rinsed again in distilled water for two hours at 60 degC to remove the salts. The water was discarded by spinning the samples at 1300 rpm for 30 minutes. The cell pellet was lysed by adding 100 µl of lysis buffer consisting of 1mM of EDTA, 50mM of Tris, 2.5% of Tween-20 and 4 µg of Proteinase K (Qiagen®) for 5 hours at 50 degC.

Tissue material from fine needle aspiration smears were rehydrated directly, without deparaffinization. Bisulphite treatment steps were followed exactly like as in FFPE sections, except the sodium bisulphite treatment, where incubation in 3M sodium bisulphite with 0.5mM hydroquinone at 60 degC, was reduced to 4 hours only.

Purification Of The Bisulphite Treated DNA
DNA was allowed to precipitate overnight with 7.7M of Ammonium acetate and 3 times more volume of absolute alcohol. The resultant pellet was washed in 70% alcohol twice and dissolved in 100 µl of water.

Methylation Specific PCR For DNA Derived From The In-Tube Bisulphite Modification Method.
PCR was carried out for a selected set of genes using 2.5 µl of template from the extracted DNA in each case, except in colon samples where templates were diluted to 10 times, as PCR inhibition was observed in direct samples. Unmethylated and methylated sets of primers for few commonly methylated genes in the majority tumour types were chosen from published literature. The selected genes, primer sequences and PCR conditions are given in (Table/Fig 1).

PCR for each gene was run with positive and no template controls. The positive control was prepared by treating DNA which was derived from the buffy coat samples of normal subjects, with Sss I (CpG Methylase), (Cat # no M0226S, NewEngland Biolab®, USA) for 18 hrs and by modifying it by bisulphite treatment. The PCR products were checked after 2% agarose gel electrophoresis and the gel images were documented by a gel doc system.

Bisulphite Modification By The Conventional Method DNA Extraction
Genomic DNA was extracted using Chelex 100 (14, 15). In brief, one10µm thick section chosen from the FFPE blocks of the samples was incubated in 0.5% of Tween-20 for 10 minutes at 95oC. After cooling it down to 55oC, 6µl of Proteinase K (concentration of 20µg/µl from Qiagen®) was added to it and it was incubated overnight. 400µl of 5% Chelex-100 was added to each sample and it was incubated at 95 oC for 10 minutes. The supernatant was collected after centrifugation for 15 minutes. 200 µl of chloroform was added to it and the upper phase was collected again after a spin for 10 minutes. DNA was precipitated using 1/10 volume of 3M sodium acetate (pH-7) and 2 volumes of 100% ethanol at -80 oC for 15 minutes. Following a spin for 15 minutes, the DNA pellet was washed with 70% ethanol twice. The DNA recovery varied between 500ng-1.5 µg for colon cancer samples, 100ng-900 ng for breast cancer samples, 50ng-300 ng for liver biopsy and 28ng-50 ng for breast FNAC samples.

Bisulphite Modification
Since the conventional method of bisulphite modification recommended the use 1 µg of DNA as the starting material for modification, only those tissues that yielded more than 1µg of DNA were used for the conventional method of bisulphite modification. The protocol was adapted from Frommer M et al (16) and was modified for the FFPE tissue. The pellet was dissolved in 25 µl of H2O.

Methylation Specific PCR For DNA Derived By The Conventional Method Of Modification
PCR was carried out in parallel with the DNA derived from the tube method of bisulphite modification for all the selected set of genes. 2.5 µl of bisulphate modified DNA was taken as the template for methylation specific PCR and the exact methodology was carried out as described above for methylation specific PCR.

Results

Results And Discussion
Given that DNA methylation is a common event in cancer, we evaluated the methylation status of some of the known genes like sFRP1 and MGMT in various tissue types. Methylation specific PCR was performed for DNA derived from both the conventional bisulphite modification and our modified protocol of the in tube bisulphite modification methods. Both the methods showed successful bisulphite modification of the DNA as seen by the results of methylation specific PCR.

DNA Methylation Patterns Of A Selected Set Of Genes In Various Tissue Types
Successful detection of methylated and unmethylated bands by methylation specific PCR (Table/Fig 2) showed that our modified method of in-tube bisulphite modification worked across various tissue types like breast, colon, liver and brain, and material derived from stained cytology smears. Amongst the genes studied, SFRP is one of the most common methylated genes in breast and colorectal cancers. Methylation was observed in 10/11 samples of colon cancer, 4/5 samples from liver biopsies and 4/5 samples of breast cancer. DNA derived from brain tumours of glioma showed methylation in the MGMT gene. Representative gels for each tissue type were shown in (Table/Fig 2) Table/Fig 2 A, B, C, D, and E.

Comparisons Of The In-Tube Bisulphite Modification Vs The Conventional Bisulphite Modification Methods By Methylation Specific PCR
The conventional method of bisulphite modification is limited by the amount of modified DNA available post modification. Though equal amounts of tissue materials were taken from the FFPE blocks for both conventional and our modified protocol of the in-tube method of bisulphite modification, equal volumes of the template used in MSP did not show amplification in the conventional method in comparison to our modified in-tube method (Table/Fig 3).

Increasing the template quantity in MSP however, showed equivalent results by the conventional method of modification, proving that there was considerable loss of DNA during the conventional method of bisulphite modification (Table/Fig 4). In contrast, modified DNA derived from samples of colon cancer by our in-tube method of modification was diluted before its use as a template in MSP, to avoid PCR inhibition by high template concentration (Table/Fig 2) Table/Fig 2 A. These results clearly demonstrate the advantage of our modified protocol of the in- tube method of bisulphite modification in yielding higher amounts of bisulphite modified DNA which could be used for testing the methylation status of multiple genes with a limited amount of tissue material. Our results also correlate well with the previously established loss of DNA by the conventional method of bisulphite modification (12).

The In Tube Method Of Bisulphite Modification On Tissue Materials Derived From Fine Needle Aspiration Smears
Fine needle aspirate smears are the next convenient tissue material available from human tissues after FFPE. To explore if the limited amount of cells available from these cytology smears could be used for the evaluation of the methylation status of various genes post modification, we standardized our techniques on stained sections of fine needle aspirates from breast cancers. Bisulphite modification by our in-tube method, followed by MSP, showed successful amplification for the gene sFRP1 [Table/Fig2] Table/Fig2E. Conventional DNA isolation by the Chelex method yielded 50 to 250 nanograms of DNA, which was insufficient for regular bisulphite modification. These results prove the superiority of our modified method of bisulphite modification over the conventional method and the in optimum utilization of scanty amounts of precious human tissue samples.

Bisulphite modification is an effective method for the detection of the patterns of DNA methylation. The success of DNA methylation however, depends on the successful conversion of the unmethylated groups and the yield of modified DNA. The conventional method of bisulphite modification has considerable loss of DNA during purification (12). Many commercially available kits and published techniques suggest the use of a minimum of 1 microgram of DNA for bisulphite modification (16). The low yield of modified DNA due to template loss limits the number of genes that can be evaluated in the given sample. This is a serious disadvantage, where only a small amount of tissue is available from archived samples. Our modified method overcomes this disadvantage by minimizing the loss of DNA and allowing the methylation analysis of multiple genes from small amounts of archived materials like formalin fixed tissue materials and fine needle aspirate smears.

The yield of modified bisulphite modified DNA is more than the yield in the conventional method, as shown by the need for the template dilution of the modified DNA in methylation specific PCR. Since the method uses only a scanty amount of tissue such as a few hundred cells as in cytology smears, it allows the judicious use of precious tissue from archived samples for testing multiple genes.

Our method has wide application, as formalin fixed tissues and fine needle aspirate cytology materials are the widest available material for the assessment of human tissue specimens. They also represent by far, the most abundant supply of solid tissue specimens associated with clinical records.

Our method of in-tube bisulphite conversion (Patent filed 366/CHE/2008) is a modification of the in situ methods described by Umetani et al (13). Unlike in their method, we have used entire tissue sections instead of microdissected areas of tissue sections. Though their method may have had the advantage of studying the differential methylation patterns in heterogeneous tumour samples, the adherence of the tissue sections onto the slides was a problem in our experience, especially for a small volume of tissue like in liver biopsies, even on coated slides. Our method of using the entire section for bisulphite modification after deparaffinization solved this problem and prevented the loss of precious tissue material. We also introduced a few modifications to the original technique, such as overnight precipitation and purification of the modified DNA after extraction. Overnight purification significantly improved the yield and purification by repeated alcohol wash removed the impurities which are seen as sharp bands in the gel images.

In conclusion we report here, a technical and experimental modification which improves previously described methods in several aspects, an easier and safer handling of samples, a shortening of the time required for the whole procedure and one that meets the standards of sensitivity and is very cost effective. In addition, the method facilitates bisulphite conversion and methylation analysis of very scanty amounts of tissues available from formalin fixed and fine needle aspirate cytology materials.


Acknowledgement

This piece of research work was carried out with full support from Health care Global Enterprises Limited.

Competing Interests Statement
The authors declare no conflict or competing interests.

References

1.
. François Gaudet J. Graeme Hodgson, Amir Eden, Laurie Jackson-Grusby, Jessica Dausman, Joe W. Gray, Heinrich Leonhardt, and Rudolf Jaenisch. 2003. Induction of tumors in mice
2.
. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation by genomic hypomethylation. Science 300: 489-92. profile of human cancer. Cancer Research 2001; 61: 3225-9.
3.
. Cindy A E, Kathleen DD, Kizuyuki K, Leonard BS . Methyl light: A high throughput assay to measure DNA methylation. Nucleic Acid Res.2000; Vol 28, No. 8
4.
. James G, Hermant JR, Graff S M, Barry DN, and Stephen B . Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 1996; 93: 9821-9826.
5.
. Raad SG., Huidong S., Chuan-Mu C., Pearlly, S. Y., and Tim Hui-Ming H. . Methylation Specific Oligonucleotide Microarray. A New Potential for High-Throughput Methylation Analysis. Genome Res 2002;12: 158-164.
6.
. Zhenggang X and Peter WL . COBRA: a sensitive and quantitative DNA methylation assay, Nucleic Acids Research 1997; 25(12): 2532–253.
7.
. Maureen C, Mylan P, Debjani D, James C S, Steven S . Measurement of Gene Expression in Archival Paraffin-Embedded Tissues. Am J Pathol. 2004; 164(1): 35-42.
8.
. Helene NA, Torben S, Ebba N, Stephen J, Hamilton D .Towards Quantitative mRNA Analysis in Paraffin-Embedded Tissues Using Real- Time Reverse Transcriptase-Polymerase Chain Reaction. J Mol Diagn 2003; 5:34–41.
9.
. Francisco J, Esteva AA, Sahin MC, Kevin C . Prognostic Role of a Multigene ReverseTranscriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy. Clin Cancer Res. 2005; 11(9): 3315-19.
10.
. Norikazu M, Tahdashi O, Shoko K. Analysis of chemical modification of RNA from formalin fixed and optimizations of molecular biology applications for such samples. Nucleic Acids Res.1999; l27 (22): 4436-4443.
11.
. Nancy Q, Myron FG, Darryl S, . In vitro mutation artifacts after formalin fixation and error prone translation synthesis during PCR. BMC Clinical Pathology 2004; 10.1186/1472-6890-4-1.
12.
. Grunau C, Clark SJ, Rosenthal A. . Bisulphite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res.2001;29: E65–5.
13.
. Umetani N, Michiel FG. de Maat, Eiji S., Hiramatsu, S., Steve M., and Dave S.B. Hoon. Methylation of p16 and Ras Association Domain Family Protein 1a during Colorectal Malignant Transformation. Mol Cancer Res. 2006; 4(5): 303-309.
14.
. Polski JM, S. Kimzey RW Percival and Grosso LE. Rapid and effective processing blood specimens for diagnostic PCR using filter paper and Chelex-100. J. Clin Pathol: Mol Pathol 1998; 51: 215-217.
15.
. Sepp R, Szabó I, Uda H. and Sakamoto H. . Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol. 1994; 47:318-23.
16.
. Frommer M, McDonald LE, Millar D S, Collis CM, Watt F, Grigg GW, Molloy PL, and Paul CL . A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci, USA. 1992; 89:1827-31.

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com